Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Fasting to Improve Insulin Secretion

NCT04607096 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT04607096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04607096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Fasting to Improve Insulin Secretion
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Recruiting
Start date
April 8, 2021
Completion date
March 1, 2027
Enrollment
200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type2, insulin secretion, intermittent fasting, prediabetes